Healthcare & Life Sciences, Pinsent Masons updates

United Kingdom

Contributed by Pinsent Masons
COVID-19 crisis: clinical trials and cross-border collaboration
  • United Kingdom
  • 25 March 2020

The current circumstances are unsettling for many reasons, not least because there is still no approved vaccination or treatment for the novel coronavirus (COVID-19). Reflecting the collaborative approach recently called for by the European Medicines Agency, the UK Medicines and Healthcare Products Regulatory Agency has indicated that it stands ready to support researchers, manufacturers and other regulators to develop medicinal products to fight and prevent the spread of COVID-19.

Current search